Article Versions Notes

Rüdesheim S, Selzer D, Mürdter T, Igel S, Kerb R, Schwab M, Lehr T. Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone. Pharmaceutics. 2022; 14(8):1734. https://doi.org/10.3390/pharmaceutics14081734

Rüdesheim, Simeon, Dominik Selzer, Thomas Mürdter, Svitlana Igel, Reinhold Kerb, Matthias Schwab, and Thorsten Lehr. 2022. "Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone" Pharmaceutics 14, no. 8: 1734. https://doi.org/10.3390/pharmaceutics14081734

Rüdesheim, S., Selzer, D., Mürdter, T., Igel, S., Kerb, R., Schwab, M., & Lehr, T. (2022). Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone. Pharmaceutics, 14(8), 1734. https://doi.org/10.3390/pharmaceutics14081734